Pathological changes in GPCR signal organisation: Opportunities for targeted therapies for triple negative breast

Terrance Lam1, Chantel Mastos1, Erica K Sloan1

  • 1Drug Discovery Biology Theme, Monash Institute of Pharmaceutical Sciences, Monash University, Parkville, Victoria 3052, Australia.

Pharmacology & Therapeutics
|December 13, 2022
PubMed

Insights

Triple negative breast cancer (TNBC) progresses due to the β2-adrenoceptor, a G protein-coupled receptor (GPCR). Targeting GPCRs in unique cellular locations offers new therapeutic strategies for TNBC.

Area of Science:

  • Oncology
  • Cell Biology
  • Pharmacology

Background:

  • Triple negative breast cancer (TNBC) has a poor prognosis and limited targeted therapies.
  • G protein-coupled receptors (GPCRs), like the β2-adrenoceptor, are emerging as potential therapeutic targets.
  • Understanding TNBC signaling pathways is crucial for developing effective treatments.

Purpose of the Study:

  • To investigate the role of the β2-adrenoceptor in TNBC progression and invasion.
  • To elucidate the unique signaling pathway activated by β2-adrenoceptor in aggressive TNBC cells.
  • To explore the therapeutic potential of targeting GPCRs in aberrant cellular locations.

Main Methods:

  • Analysis of signaling pathways in TNBC tumor cells.
  • Investigating the function of β2-adrenoceptor in response to stress.
  • Studying GPCR organization and localization within tumor cells.

Main Results:

  • The β2-adrenoceptor accelerates TNBC progression under stress.
  • A unique signaling pathway activated by β2-adrenoceptor drives aggressive TNBC cell invasion.
  • Evidence suggests altered GPCR organization in tumor cells, leading to unique cellular responses.

Conclusions:

  • The β2-adrenoceptor is a key driver of TNBC progression and invasion.
  • Aberrant GPCR localization in tumor cells presents novel therapeutic opportunities.
  • Targeted anti-cancer GPCR drugs could offer improved efficacy and reduced side effects.

Related Concept Videos

Amplifying Signals via Enzymatic Cascade01:22

Amplifying Signals via Enzymatic Cascade

When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze...
8.6K
G Protein-coupled Receptors01:15

G Protein-coupled Receptors

G Protein-Coupled Receptors or GPCRs are membrane-bound receptors that transiently associate with heterotrimeric G proteins and induce an appropriate response to sensory stimuli such as light, odors, hormones, cytokines, or neurotransmitters.
GPCRs are also called heptahelical, 7TM, or serpentine receptors, and consist of seven (H1-H7) transmembrane alpha-helices that span the bilayer to form a cylindrical core. The transmembrane helices are connected by three extracellular loops and three...
12.6K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.8K
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
6.4K
GPCR Desensitization01:12

GPCR Desensitization

G protein-coupled receptor (GPCR) signaling plays a crucial role in cell functioning. GPCR desensitization is an equally essential process. It allows cells to respond to changing environments and regain sensitivity to new stimuli while preventing unnecessary stimulation when no longer needed. Prolonged exposure to stimuli leads to GPCR desensitization. It involves blocking the receptors from binding and activating additional G proteins. This inhibits activation of downstream effectors, thereby...
6.2K
Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR...
2.1K